Adrián Llerena RuÃz
Madrid Health Service
Sant Pau Biomedical Research Institute
Spain
Biography
Academic and Professional titles: - Medical Specialist in Clinical Pharmacology. - Doctor of medicine and surgery. Current position: - Full Professor of University. Area of ​​Pharmacology, Department of Surgical Medical Therapeutics, Faculty of Medicine, University of Extremadura. - Director of CICAB, Extremadura Health Service. - Coordinator Official Program of Postgraduate and Doctorate in "Management of Biomedical Knowledge and Clinical Research" Previous positions: - 89-93. Visiting Scientist, Dpt. of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden .. - 2003-05 Visiting Professor. Dpt. of Psychiatry. Center for Pharmacogenomics and Clinical Pharmacology. UCLA University of Caligo ia Los Angeles, USA. 2001-Act. Professor Clinical Pharmacology. University Beira Inerior. Fac. Sciences Saude, Portugal. - 2005 Visiting Professor. Dpt. of Psychiatry, Mount Snai Hospital and Medical School, NYC, New York, USA. - 2006 Visiting Professor. Dpt. of Psychiatry, Miller School of Medicine, University of Miami Hospital, Miami, FL, USA. - 2005 - actuality. Coordinator Ibero-American Network of Pharmacogenetics and Pharmacogenomics www.ribef.org. CV Summary: Inte Ational Peer Review Articles: 101 PI (Grants): 25 Evaluations: (3 Sexenes Research CNEAI, 5 quinquennial) Editorial Committee: The Pharmacogenomics Jou al (Nature), Current Drug Targets, Current Pharmacogenetics, Open Jou al of Clinical Pharmacology. Research lines: Clinical Psychopharmacology, Pharmacogenetics of Psychopharmaceuticals, Clinical Trials, Pharmacovigilance. University of Miami Hospital, Miami, FL, USA. - 2005 - actuality. Coordinator Ibero-American Network of Pharmacogenetics and Pharmacogenomics www.ribef.org. CV Summary: Inte Ational Peer Review Articles: 101 PI (Grants): 25 Evaluations: (3 Sexenes Research CNEAI, 5 quinquennial) Editorial Committee: The Pharmacogenomics Jou al (Nature), Current Drug Targets, Current Pharmacogenetics, Open Jou al of Clinical Pharmacology. Research lines: Clinical Psychopharmacology, Pharmacogenetics of Psychopharmaceuticals, Clinical Trials, Pharmacovigilance. University of Miami Hospital, Miami, FL, USA. - 2005 - actuality. Coordinator Ibero-American Network of Pharmacogenetics and Pharmacogenomics www.ribef.org. CV Summary: Inte Ational Peer Review Articles: 101 PI (Grants): 25 Evaluations: (3 Sexenes Research CNEAI, 5 quinquennial) Editorial Committee: The Pharmacogenomics Jou al (Nature), Current Drug Targets, Current Pharmacogenetics, Open Jou al of Clinical Pharmacology. Research lines: Clinical Psychopharmacology, Pharmacogenetics of Psychopharmaceuticals, Clinical Trials, Pharmacovigilance. The Pharmacogenomics Jou al (Nature), Current Drug Targets, Current Pharmacogenetics, Open Jou al of Clinical Pharmacology. Research lines: Clinical Psychopharmacology, Pharmacogenetics of Psychopharmaceuticals, Clinical Trials, Pharmacovigilance. The Pharmacogenomics Jou al (Nature), Current Drug Targets, Current Pharmacogenetics, Open Jou al of Clinical Pharmacology. Research lines: Clinical Psychopharmacology, Pharmacogenetics of Psychopharmaceuticals, Clinical Trials, Pharmacovigilance.
Research Interest
Pharmacology
Publications
-
Llerena A1, Dorado P, Peñas-Lledó EM. Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.Pharmacogenomics. 2009 Jan;10(1):17-28.
-
Peñas-LLedó EM, Lerena AL (2012) CYP2D6 Ultrarapid Metabolism and Suicide. J Pharmacogenom Pharmacoproteomics 3:e112.
-
M E G Naranjo1, F de Andrés1, A Delgado1, J Cobaleda1,2, E M Peñas-Lledó1,4 and A LLerena. High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies. The Pharmacogenomics Journal (2016) 16, 485–490